Why the study?
Does pre-procedural moderate to advanced chronic kidney disease increase mortality in patients undergoing TAVI?
Population
3,980 patients undergoing transcatheter aortic valve implantation (TAVI) in the UK between 2007 and 2012
Comparison
Moderate to advanced chronic kidney disease vs Patients with better renal function
Design
Cohort
Follow-up
median 543 days
Authors
Loading...
Highlights CKD in pre-TAVI risk assessment; leaves open whether targeted interventions improve survival.
Does pre-procedural moderate to advanced chronic kidney disease increase mortality in patients undergoing TAVI?
Pre-procedural renal dysfunction is independently associated with increased in-hospital and long-term mortality following TAVI.
Ferro et al. (2015) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: